Poor
Needs Revision
Patient Risk:
Medium
Summary
Multiple AI claims are not supported by the provided FDA label excerpts, including exercise/physical activity guidance, falls/injury risk, coordination/balance effects, and fibromyalgia-exercise utility, which materially reduce label alignment.
Category Scores
Accurate Statements
Lyrica (pregabalin) can cause dizziness and drowsiness.
Supported: 5.5 Dizziness and Somnolence
Lyrica (pregabalin) can cause weight gain and swelling.
Supported: 5.8 Weight Gain and 5.7 Peripheral Edema
Lyrica (pregabalin) can cause dizziness and lightheadedness, especially when standing up quickly or engaging in physical activity.
Partially supported: 5.5 Dizziness and Somnolence (added specifics about standing/physical activity not supported by provided text)
Lyrica (pregabalin) can cause nausea and vomiting.
Partially supported only in the context of abrupt/rapid discontinuation: 5.6 Increased Risk of Adverse Reactions with Abrupt or Rapid Discontinuation (label text includes nausea and headache after abrupt/rapid discontinuation; presented as a general side effect is not fully supported)
Lyrica (pregabalin) can cause dry mouth and blurred vision.
Partially supported: 5.10 Ophthalmological Effects supports blurred vision; dry mouth is not supported by the provided excerpts
Lyrica can cause short-term side effects such as dizziness, fatigue, and muscle pain.
Partially supported: 5.5 supports dizziness and somnolence; fatigue and muscle pain are not supported by provided excerpts
Unsupported Statements
Lyrica (pregabalin) can cause headaches and fatigue.
No provided label excerpt supports headaches/fatigue as general adverse reactions.
Lyrica (pregabalin) can increase the risk of falls and injuries during physical activity.
No provided label excerpt supports falls/injuries risk.
Lyrica (pregabalin) can cause fatigue and weakness.
No provided label excerpt supports fatigue/weakness as adverse reactions.
Lyrica (pregabalin) can make it difficult to engage in physical activity or exercise.
No provided label excerpt supports difficulty exercising/physical activity.
Lyrica (pregabalin) can cause muscle pain and stiffness, especially in the arms and legs.
No provided label excerpt supports muscle pain/stiffness.
Lyrica (pregabalin) can affect coordination and balance.
No provided label excerpt supports coordination/balance effects.
Lyrica (pregabalin) can make it difficult to engage in physical activities that require balance and coordination.
No provided label excerpt supports balance/coordination-related functional limitation.
Exercise can be a useful adjunctive treatment for patients with fibromyalgia.
No provided label excerpt states exercise as adjunctive treatment; 14.4 addresses efficacy of Lyrica for fibromyalgia, not exercise.
Exercise should be used with caution in patients taking pregabalin (Lyrica).
No provided label excerpt provides exercise/physical activity caution guidance.
With regular exercise, long-term benefits such as improved mood, reduced anxiety, and increased energy levels may be experienced.
No provided label excerpt links exercise to mood/anxiety/energy benefits.
Contradictions
Important Omissions
No evaluation/citations provided for boxed warnings, contraindications, dosing/administration, drug interactions, or key warnings beyond the limited excerpts supplied; therefore label completeness for safety context cannot be confirmed.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
Unsupported guidance regarding exercise/physical activity, falls/injuries risk, and coordination/balance effects could mislead patients or clinicians if presented as label-grounded counseling. Several adverse effects (e.g., dizziness/somnolence, weight gain, peripheral edema) are supported, but multiple additional claims are not.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Needs Revision
Primary Issue
Significant number of claims are not supported by the provided FDA label excerpts (especially exercise/physical activity and functional/balance/falls-related statements).
Suggested Improvement
Remove or strictly rephrase unsupported exercise/physical activity, falls/injuries, coordination/balance, and fibromyalgia-exercise utility claims, and ensure nausea/vomiting is limited to the labeled context (abrupt/rapid discontinuation) if included.